A Multidisciplinary Core Team
The three Directors have different specialties: Roberto Lorusso is a cardiac surgeon, Sascha Ott a cardiac intensivist and Flavio Ribichini a interventional cardiologist. 40 other healthcare practitioners will be assigned to one of 5 working groups:
- Patient and MCS device phenotyping
- Implantation and complication management
- Shock network and patient care
- MCS evidence and outcomes
- Innovation
Directors
The working group leaders and members
| Patient & MCS device phenotyping | Implantation and complication management | Shock network / Patient care | MCS evidence & outcomes | Innovation |
|---|---|---|---|---|
Federico Pappalardo | Jan Belohlavek | Hatem Soliman | Christophe Vandenbriele | Daniel Zimpfer |
Anna Mara Scandroglio | Albert Ariza-Sole | Tim Balthazar | Christiaan Meuwese | Gabor G. Toth |
Alexandre Mebazaa | Claudio Russo | Thijs Delnoij | Paolo Meani | Benedikt Schrage |
Monica Fürholz | Jan Pudil | Gianluca Paternoster | Pia Lanmuller | Ivan Netuka |
Sern Lim | Gabriele Pesarini | Miguel Pinon | Bastian Schmack | Filip De Somer |
Evgenij Potapov | Stanislaw Bartus | Marina Pieri | Albana Frroku | Bernd Panholzer |
Pascal Vranckx | Christian Napp | Marko Noc | Holger Thiele | Lukas Hunziker Munsch |
Andrea Montisci | Danilo Franco | Jose Henriques | Marianna Adamo | Javier Escaned |
Thevathasan Tharusan | Eduardo Celentano | Francesco Onorati | ||
Pedro Villablanca | Azeem Latib | |||
Divaka Perera | ||||
Tom De Potter |
Valid as of 27 April 2026
Sincere thanks and recognition to Abiomed, founding partner of the PCR MCS Focus Group.